Treatment of Dyshidrotic Eczema
Topical corticosteroids are the first-line treatment for dyshidrotic eczema, with potency selection based on severity, accompanied by emollients and soap substitutes for maintenance therapy. 1
First-Line Treatment Approach
Topical Corticosteroids
- Acute phase treatment:
- High-potency corticosteroids for severe cases
- Medium-potency for moderate cases
- Low-potency for mild cases 1
- Application frequency: Once daily application is as effective as twice daily for potent corticosteroids 2
- Duration: Short-term use (2-4 weeks) to avoid side effects such as skin atrophy, telangiectasias, and striae 1
Emollients and Moisturizers
- Apply liberally and frequently (3-8 times daily)
- Use even when skin appears normal
- Apply immediately after bathing to trap moisture
- Choose fragrance-free formulations 1
Second-Line Treatments
Topical Calcineurin Inhibitors
- Tacrolimus 0.1% ointment is effective for patients unresponsive to or intolerant of topical corticosteroids 1
- Apply as a thin layer to affected areas twice daily until clearance of lesions 1
- Can be used for rotational therapy with corticosteroids in chronic cases 3
Protective Measures
- Keep nails short to prevent scratching
- Use cotton clothing
- Avoid extremes of temperature
- Use soap substitutes for cleansing 1
Treatment for Refractory Cases
Phototherapy
- Oral PUVA (Psoralen + UVA) has shown superior efficacy for hand eczema
- Significant improvement or clearance in 81-86% of patients with hand and foot eczema 1
Systemic Therapies
For severe, refractory cases:
- Oral corticosteroids (prednisone 1 mg/kg/day with tapering over at least 4 weeks) 1
- Immunomodulators (cyclosporine, methotrexate, azathioprine) for moderate-to-severe cases unresponsive to topical therapies 1
Infection Management
- Treat clinically evident infections with appropriate antibiotics
- Consider antiseptic washes with aqueous chlorhexidine 0.05% for erosive lesions
- Bleach baths with 0.005% sodium hypochlorite twice weekly can help prevent infections 1
Special Considerations
Maintenance Therapy
- Weekend (proactive) application of topical corticosteroids significantly reduces relapse rates compared to reactive treatment 2
- This approach decreases likelihood of relapse from 58% to 25% 2
Monitoring for Adverse Effects
- Local adverse events like skin thinning are rare (reported in only 1% of patients in clinical trials)
- Risk increases with higher potency corticosteroids and longer duration of use 2
- Regular monitoring for skin atrophy is essential, especially with prolonged use
When to Refer to a Specialist
- Diagnostic uncertainty
- Poor response to initial treatment
- Severe or widespread disease requiring systemic therapy
- Need for patch testing to identify potential allergens 1
Treatment Algorithm
- Mild cases: Low-potency topical corticosteroid once daily + emollients
- Moderate cases: Medium-potency topical corticosteroid once daily + emollients
- Severe cases: High-potency topical corticosteroid once daily + emollients
- If inadequate response after 2-4 weeks: Consider topical tacrolimus or referral for phototherapy
- For chronic/recurrent cases: Consider weekend maintenance therapy with topical corticosteroids
- For refractory cases: Consider systemic therapy or phototherapy under specialist supervision
Remember that dyshidrotic eczema often runs a chronic, relapsing course, and long-term management strategies are essential for optimal outcomes 3.